Add to ORKG© 2016 Anwar et al. Background and purpose: Treatment of intermediate and high-risk prostate cancer with a high BED has been shown to increase recurrence free survival (RFS). While high dose rate (HDR) brachytherapy, given as a boost is effective in deliv
Prostate cancer is the most commonly diagnosed cancer among men around the world. Radiotherapy is a ...
Objective: The addition of androgen deprivation therapy (ADT) to conventional radiation therapy impr...
There have been significant improvements in the radiotherapeutic management of patients with high ri...
© 2016 Anwar et al. Background and purpose: Treatment of intermediate and high-risk prostate cancer ...
Background: There is growing evidence that prostate cancer (PC) cells are more sensitive to high fra...
Purpose/Objective: To evaluate the outcome of prostate cancer patients treated with a combination of...
PURPOSE: The radiobiology of prostate cancer may favor the extreme hypofractionation inherent in ste...
PurposeStereotactic body radiation therapy (SBRT) is increasingly being used for the management of l...
INTRODUCTION: To examine the long-term outcomes of high dose rate brachytherapy boost (HDR-BT) combi...
BACKGROUND: The objective of this study was to determine whether the addition of low-dose-rate brach...
Purpose: We report the outcome of hypofractionated proton boost as an alternative to high dose-rate ...
Prostate cancer is the most common non-cutaneous cancer in males. There are a number of options for ...
High-risk prostate cancer is an aggressive form of the disease with an increased risk of distant met...
Purpose There is no consensus on how to treat high-risk prostate cancer, and long-term results from ...
Purpose Whole pelvis radiation therapy (WPRT) may improve clinical outcomes over prostate-only radi...
Prostate cancer is the most commonly diagnosed cancer among men around the world. Radiotherapy is a ...
Objective: The addition of androgen deprivation therapy (ADT) to conventional radiation therapy impr...
There have been significant improvements in the radiotherapeutic management of patients with high ri...
© 2016 Anwar et al. Background and purpose: Treatment of intermediate and high-risk prostate cancer ...
Background: There is growing evidence that prostate cancer (PC) cells are more sensitive to high fra...
Purpose/Objective: To evaluate the outcome of prostate cancer patients treated with a combination of...
PURPOSE: The radiobiology of prostate cancer may favor the extreme hypofractionation inherent in ste...
PurposeStereotactic body radiation therapy (SBRT) is increasingly being used for the management of l...
INTRODUCTION: To examine the long-term outcomes of high dose rate brachytherapy boost (HDR-BT) combi...
BACKGROUND: The objective of this study was to determine whether the addition of low-dose-rate brach...
Purpose: We report the outcome of hypofractionated proton boost as an alternative to high dose-rate ...
Prostate cancer is the most common non-cutaneous cancer in males. There are a number of options for ...
High-risk prostate cancer is an aggressive form of the disease with an increased risk of distant met...
Purpose There is no consensus on how to treat high-risk prostate cancer, and long-term results from ...
Purpose Whole pelvis radiation therapy (WPRT) may improve clinical outcomes over prostate-only radi...
Prostate cancer is the most commonly diagnosed cancer among men around the world. Radiotherapy is a ...
Objective: The addition of androgen deprivation therapy (ADT) to conventional radiation therapy impr...
There have been significant improvements in the radiotherapeutic management of patients with high ri...